Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit

By Isaka M.   Yasuda Y.   Kozuka S.   Miura Y.   Taniguchi T.   Matano K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 16, Iss. 17, 1998-10 ,pp. : 1620-1626

Elsevier

Access to resources Recommend Favorite

The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines

By Baudner B.C.   Giuliani M.M.   Verhoef J.C.   Rappuoli R.   Junginger H.E.   Giudice G.D.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3837-3844

Elsevier

Access to resources Recommend Favorite

Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals

By Sonmez E.   Sonmez A.S.   Bayindir Y.   Coskun D.   Ariturk S.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 243-246

Elsevier

Access to resources Recommend Favorite

Adequate immune response to tetanus toxoid and failure of vitamin A and E supplementation to enhance antibody response in healthy children

By Kutukculer N.   Akil T.   Egemen A.   Kurugol Z.   Aksit S.   Ozmen D.   Turgan N.   Bayindir O.   Caglayan S.  

Vaccine, Vol. 18, Iss. 26, 2000-07 ,pp. : 2979-2984

Elsevier

Access to resources Recommend Favorite

Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination

By Kruger S.   Seyfarth M.   Sack K.   Kreft B.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1145-1150

Elsevier

Access to resources Recommend Favorite